These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9152782

  • 1. Captopril reduced plasminogen activator inhibitor activity in patients with acute myocardial infarction.
    Moriyama Y, Ogawa H, Oshima S, Takazoe K, Honda Y, Hirashima O, Arai H, Sakamoto T, Sumida H, Suefuji H, Kaikita K, Yasue H.
    Jpn Circ J; 1997 Apr; 61(4):308-14. PubMed ID: 9152782
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction.
    Goto S, Kawai Y, Handa S, Abe S, Takahashi E, Watanabe K, Hori S, Ikeda Y.
    Cardiology; 1993 Apr; 82(4):280-5. PubMed ID: 8402755
    [Abstract] [Full Text] [Related]

  • 9. ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time.
    Brown NJ, Kumar S, Painter CA, Vaughan DE.
    Hypertension; 2002 Dec; 40(6):859-65. PubMed ID: 12468570
    [Abstract] [Full Text] [Related]

  • 10. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
    Pedersen OD, Gram J, Bagger H, Keller N, Jespersen J.
    Coron Artery Dis; 1994 Jul; 5(7):617-23. PubMed ID: 7952424
    [Abstract] [Full Text] [Related]

  • 11. Alterations in the fibrinolytic system components during acute myocardial infarction.
    Ioannidou-Papayannaki E, Lefkos N, Boudonas G, Efthimiadis A, Psirropoulos D, Vogas V, Papadopoulos I, Klonizakis I.
    Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension.
    Jeng JR, Harn HJ, Yueh KC, Jeng CY, Shieh SM.
    Am J Hypertens; 1998 Feb; 11(2):235-9. PubMed ID: 9524054
    [Abstract] [Full Text] [Related]

  • 13. Questioning a class effect: does ACE inhibitor tissue penetration influence the degree of fibrinolytic balance alteration following an acute myocardial infarction?
    Tsikouris JP, Suarez JA, Meyerrose GE, Ziska M, Fike D, Smith J.
    J Clin Pharmacol; 2004 Feb; 44(2):150-7. PubMed ID: 14747423
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction.
    Gray RP, Patterson DL, Yudkin JS.
    Arterioscler Thromb; 1993 Mar; 13(3):415-20. PubMed ID: 8443145
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F, Alessi MC, Morange P, Maixent JM, Lévy S, Vague IJ.
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.